Risk of Recurrent Venous Thromboembolism and Bleeding in Cancer Patients Treated With Direct Oral Anticoagulants Versus Low-molecular-weight Heparin

被引：1
|
作者：
Long, Brit [1 ]
Koyfman, Alex [2 ]
Gottlieb, Michael [3 ]
机构：
[1] Brooke Army Med Ctr, Dept Emergency Med, Ft Sam Houston, TX 78234 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Emergency Med, Dallas, TX 75390 USA
[3] Rush Univ, Med Ctr, Dept Emergency Med, Chicago, IL 60612 USA
来源：
ACADEMIC EMERGENCY MEDICINE | 2020年 / 27卷 / 02期
关键词：
AMERICAN SOCIETY; PROPHYLAXIS; GUIDELINE; DISEASE;
D O I：
10.1111/acem.13855
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：170 / 172
页数：3
相关论文
共 50 条
  • [1] Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
    Lee, AYY
    Levine, MN
    Baker, RI
    Bowden, C
    Kakkar, AK
    Prins, M
    Rickles, FR
    Julian, JA
    Haley, S
    Kovacs, MJ
    Gent, M
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (02): : 146 - 153
  • [2] Is recurrent venous thromboembolism after therapy reduced by low-molecular-weight heparin compared with oral anticoagulants?
    Ferretti, Gianluigi
    Bria, Emilio
    Giannarelli, Diana
    Carlini, Paolo
    Felici, Alessandra
    Mandala, Mario
    Papaldo, Paola
    Fabi, Alessandra
    Ciccarese, Mariangela
    Cuppone, Federica
    Cecere, Fabiana Letizia
    Nuzzo, Carinen
    Terzoli, Edmondo
    Cognetti, Francesco
    CHEST, 2006, 130 (06) : 1808 - 1816
  • [3] Assessment of venous thromboembolism treatment in patients with cancer on low molecular weight heparin, warfarin, and the direct oral anticoagulants
    Uppuluri, Ellen M.
    Burke, Kelly R.
    Haaf, Christina Mactal
    Shapiro, Nancy L.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (02) : 261 - 268
  • [4] Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors
    Lee, Angela
    Oley, Frank, Jr.
    Lo, Mimi
    Fong, Richard
    McGann, Mary
    Saunders, Ila
    Block, Shanna
    Mahajan, Anjlee
    Pon, Tiffany K.
    THROMBOSIS RESEARCH, 2021, 208 : 148 - 155
  • [5] Safety and Efficacy of Direct Oral Anticoagulants vs Low Molecular Weight Heparin for Treatment of Venous Thromboembolism in Patients With Cancer
    Singh, Sahib
    Tantry, Udaya
    Bliden, Kevin
    Gurbel, Paul
    CIRCULATION, 2023, 148
  • [6] Recurrent venous thromboembolism in cancer patients treated with direct oral anticoagulants.
    Talbot, Alice
    Dean, Andrew Peter
    Brennan, Ciara
    Talbot, Thomas
    Angelov, Sophia
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Low-molecular-weight heparin prescribing for venous thromboembolism in cancer patients
    Stewart, David
    Rikhye, Somi
    Odle, Brian
    Flores, Emily
    PHARMACOTHERAPY, 2013, 33 (05): : E51 - E51
  • [8] Decreased Bleeding Incidence with Direct Oral Anticoagulants Compared to Vitamin K Antagonist and Low-Molecular-Weight Heparin in Patients with Sickle Cell Disease and Venous Thromboembolism
    Patel, Ameet
    Williams, Hants
    Baer, Maria R.
    Zimrin, Ann B.
    Law, Jennie Y.
    ACTA HAEMATOLOGICA, 2019, 142 (04) : 233 - 238
  • [9] Direct Oral Anticoagulants versus Low Molecular Weight Heparin for Venous Thromboembolism in Cancer Patients: An Updated Systematic Review and Meta-Analysis
    Akbar, Usman
    Mughal, Ahmad Kabir
    Khan, Ahmad Ali
    Umer, Ahmed Muaaz
    Malik, Saad U.
    Shamshad, Talha
    Ali, Ahmed
    Shafique, Nouman
    Danish, Ali
    Anwar, Rana Usman
    Rasool, Muhammad Wajid
    CIRCULATION, 2023, 148
  • [10] Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats
    O'Connell, Casey
    Escalante, Carmen P.
    Goldhaber, Samuel Z.
    McBane, Robert
    Connors, Jean M.
    Raskob, Gary E.
    ONCOLOGIST, 2021, 26 (01): : E8 - E16
12345